L-655,708

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C18H19N3O4
Molecular Weight	341.3612
Optical Activity	UNSPECIFIED
Defined Stereocenters	1 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of L-655,708

Structure Search

SMILES

[H][C@@]12CCCN1C(=O)C3=CC(OC)=CC=C3N4C=NC(C(=O)OCC)=C24

InChI

InChIKey=YKYOQIXTECBVBB-AWEZNQCLSA-N

InChI=1S/C18H19N3O4/c1-3-25-18(23)15-16-14-5-4-8-20(14)17(22)12-9-11(24-2)6-7-13(12)21(16)10-19-15/h6-7,9-10,14H,3-5,8H2,1-2H3/t14-/m0/s1

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary Target	Pharmacology	Condition	Potency
GABA receptor alpha-5 subunit 8 Target ID: CHEMBL5112 Sources: https://www.ncbi.nlm.nih.gov/pubmed/9014149	Binding Agent 1064		2.4 nM [Kd]

Name

Type

Language

L-655,708

Code

English

9H-IMIDAZO(1,5-A)PYRROLO(2,1-C)(1,4)BENZODIAZEPINE-1-CARBOXYLIC ACID, 11,12,13,13A-TETRAHYDRO-7-METHOXY-9-OXO-, ETHYL ESTER, (13AS)-

Systematic Name

English

L-655708

Code

English

MSD

Common Name

English

(13AS)-11,12,13,13A-TETRAHYDRO-7-METHOXY-9-OXO-9H-IMIDAZO(1,5-A)PYRROLO(2,1-C)(1,4)BENZODIAZEPINE-1-CARBOXYLIC ACID ETHYL ESTER

Systematic Name

English

Code System Code Type Description

CAS

130477-52-0

Created by admin on Sat Dec 16 16:31:36 GMT 2023 , Edited by admin on Sat Dec 16 16:31:36 GMT 2023

PRIMARY

WIKIPEDIA

L-655,708

Created by admin on Sat Dec 16 16:31:36 GMT 2023 , Edited by admin on Sat Dec 16 16:31:36 GMT 2023

PRIMARY

FDA UNII

L4BX842T8C

Created by admin on Sat Dec 16 16:31:36 GMT 2023 , Edited by admin on Sat Dec 16 16:31:36 GMT 2023

PRIMARY

EPA CompTox

DTXSID901017625

Created by admin on Sat Dec 16 16:31:36 GMT 2023 , Edited by admin on Sat Dec 16 16:31:36 GMT 2023

PRIMARY

PUBCHEM

5311203

Created by admin on Sat Dec 16 16:31:36 GMT 2023 , Edited by admin on Sat Dec 16 16:31:36 GMT 2023

PRIMARY

SUBSTANCE RECORD


					L4BX842T8C

L-655,708